This presentation addresses psychotherapuetic treatment of attention-deficit/hyperactivity disorder in adults. A brief overview is presented of the current conceptualization of this disorder in the current edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-5). A brief discussion is set forth regarding mental health counseling therapies that have demonstrated effectiveness in helping adults to cope and improve social and occupational functionality.
This presentation might be useful as an introduction to psychotherapeutic treatment of ADHD in adults, particularly within an undergraduate or lower-level graduate course in psychology or mental health counseling.
Presentatie autisme escap 2015m4 madrid how_malleable_is_autism_escap_postUtrecht
KEYNOTE abstract by professor Sally Rogers (UC Davis MIND Institute, Sacramento) titled 'How malleable is autism? Outcome studies from the youngest children with ASD', held at the ESCAP 2015 Congress in Madrid, Monday June 22nd 2015
KEYNOTE presentation (June 2015), ESCAP Expert Paper (July 2015), TV interview and abstract by professor Beate Herpertz-Dahlmann (Aachen University) on new developments in the diagnostics and treatment of adolescent eating disorders
Written in response to Misattributions and Potential Consequences: The Case of Child Mental Health Problems and Fetal Alcohol Spectrum Disorders. John D. McLennon. Canadian Journal of Psychiatry. Vol 60, No 12, December 2015.
Not published: too many words and references
Presentatie autisme escap 2015m4 madrid how_malleable_is_autism_escap_postUtrecht
KEYNOTE abstract by professor Sally Rogers (UC Davis MIND Institute, Sacramento) titled 'How malleable is autism? Outcome studies from the youngest children with ASD', held at the ESCAP 2015 Congress in Madrid, Monday June 22nd 2015
KEYNOTE presentation (June 2015), ESCAP Expert Paper (July 2015), TV interview and abstract by professor Beate Herpertz-Dahlmann (Aachen University) on new developments in the diagnostics and treatment of adolescent eating disorders
Written in response to Misattributions and Potential Consequences: The Case of Child Mental Health Problems and Fetal Alcohol Spectrum Disorders. John D. McLennon. Canadian Journal of Psychiatry. Vol 60, No 12, December 2015.
Not published: too many words and references
Emotional intelligence-as-an-evolutive-factor-on-adult-with-adhdRosa Vera Garcia
ADHD adults exhibit deficits in emotion recognition, regulation, and expression. Emotional intelligence (EI) correlates with better life performance and is considered a skill that can be learned and developed. The aim of this study was to assess EI development as ability in ADHD adults, considering the effect of comorbid psychiatric disorders and previous diagnosis of ADHD. Method: Participants (n = 116) were distributed in four groups attending to current comorbidities and previous ADHD diagnosis, and administered the Mayer–Salovey–Caruso Emotional Intelligence Test version 2.0 to assess their EI level. Results: ADHD adults with comorbidity with no previous diagnosis had lower EI development than healthy controls and the rest of ADHD groups. In addition, ADHD severity in childhood or in adulthood did not influence the current EI level. Conclusion: EI development as a therapeutic approach could be of use in ADHD patients with comorbidities.
iCAAD London 2019 - Dr Alberto Pertusa - Addiction treatment: What new medica...iCAADEvents
In this presentation, Consultant Psychiatrist and international addictions specialist, Dr McPhillips, will provide an overview of emerging medical treatments for addiction and Dr Pertusa will discuss ADHD & addiction.
This program is part of a comprehensive School Mental Health and High School Curriculum Guide.
Find out more about the guide by visiting:
teenmentalhealth.org
Emotional intelligence-as-an-evolutive-factor-on-adult-with-adhdRosa Vera Garcia
ADHD adults exhibit deficits in emotion recognition, regulation, and expression. Emotional intelligence (EI) correlates with better life performance and is considered a skill that can be learned and developed. The aim of this study was to assess EI development as ability in ADHD adults, considering the effect of comorbid psychiatric disorders and previous diagnosis of ADHD. Method: Participants (n = 116) were distributed in four groups attending to current comorbidities and previous ADHD diagnosis, and administered the Mayer–Salovey–Caruso Emotional Intelligence Test version 2.0 to assess their EI level. Results: ADHD adults with comorbidity with no previous diagnosis had lower EI development than healthy controls and the rest of ADHD groups. In addition, ADHD severity in childhood or in adulthood did not influence the current EI level. Conclusion: EI development as a therapeutic approach could be of use in ADHD patients with comorbidities.
iCAAD London 2019 - Dr Alberto Pertusa - Addiction treatment: What new medica...iCAADEvents
In this presentation, Consultant Psychiatrist and international addictions specialist, Dr McPhillips, will provide an overview of emerging medical treatments for addiction and Dr Pertusa will discuss ADHD & addiction.
This program is part of a comprehensive School Mental Health and High School Curriculum Guide.
Find out more about the guide by visiting:
teenmentalhealth.org
15 Disruptive, Impulse-Control, and Conduct DisordersThis chapte.docxaulasnilda
15 Disruptive, Impulse-Control, and Conduct Disorders
This chapter contains an amalgam of disruptive, impulse-control and conduct disorders (CDs) characterized by externalizing behaviors previously spread throughout many chapters of earlier DSM editions. However, these disorders are no longer categorized by age (e.g., disorders of infancy, childhood, and adolescence), and all share the loss of restraint (i.e., poor control) in terms of an individual's emotional or behavioral responses that are demarcated by an infringement on the rights of others or breach of social norms. Attention should be paid to the symptom overlap that these diverse disorders share with Attention Deficit/Hyperactivity Disorder (ADHD) (which can be found in Chapter 2 on Neurodevelopmental Disorders); Disruptive Mood Dysregulation Disorder (DMDD) (which can be found in Chapter 5 on Depressive Disorders); Substance Use Disorders (SUDs) (the adjoining Chapter 16), as well as Antisocial Personality Disorder (which has a dual recording in both this chapter and in Chapter 18 on Personality Disorders) (APA, 2013).
First on the hierarchical spectrum of externalizing disorders in this chapter is Oppositional Defiant Disorder (ODD). An individual with must display at least four out of eight symptoms/behaviors with an individual who is not a sibling for at least 6 months from the following three categories: (1) angry/irritable mood; (2) argumentative/defiant behavior; and (3) vindictiveness. For example, argumentative/defiant behavior symptoms include: being argumentative; demonstrating a lack of compliance with authority figures' requests; annoying others deliberately; and blaming others for his or her mistakes. The anger/irritability category symptoms include loss of temper; getting easily upset and/or annoyed, and anger/resentment. The final category has only one symptom vindictiveness or spitefulness demonstrated at least two times within the previous 6 months (APA, 2013).
Many symptoms of this diagnosis are commonly displayed during normal childhood/adolescent developmental stages. Therefore, in an effort to help differentiate the symptoms that are characteristic of this diagnosis, practitioners are cautioned to consider the persistence and frequency of behaviors. For example, in young children under the age of 5, the symptoms must occur for the majority of days for at least 6 months. For older individuals, the symptoms must occur at least once weekly within a 6-month period. However, for vindictiveness regardless of age, the criterion is the same, twice within the previous 6-month period. Along with frequency, other factors must be taken into consideration, such as symptom intensity, and whether symptoms are normal given the individual's age, developmental stage, gender, and culture. In addition, the symptoms must cause significant suffering in the individual or in his/her immediate relationships (e.g., family, friends, peers) as well as impairment in psychosocial funct ...
Week 4 6446 Therapeutic Approaches for Disruptive Behaviors ladonnacamplin
Week 4 6446 Therapeutic Approaches for Disruptive Behaviors
You must use the Readings here
· Boyatzis, C. J., & Junn, E. N. (2016).
Annual editions: Child growth and development
(22nd ed.). McGraw-Hill Education.
o Louis, C.S. “Certain Television Fare Can Help Ease Aggression in Young Children, Study Finds” (p. 83)
· Klein, B., Damiani-Taraba, G., Koster, A., Campbell, J., & Scholz, C. (2015). Diagnosing attention-deficit hyperactivity disorder (ADHD) in children involved with child protection services: are current diagnostic guidelines acceptable for vulnerable populations?.
Child: care, health and development
,
41
(2), 178-185.
· Powers, C. J., & Bierman, K. L. (2013). The multifaceted impact of peer relations on aggressive-disruptive behavior in early elementary school.
Developmental Psychology
,
49
(6), 1174– 1186.
·
Document:
DSM-5 Bridge Document: Disruptive Behaviors (PDF)
· Boyatzis, C. J., & Junn, E. N. (2016).
Annual editions: Child growth and development
(22nd ed.). McGraw-Hill Education.
o Lahey, J. “Why Parents Need to Let Their Children Fail” (p. 112)
o Smith, B. L., “The Case Against Spanking: Physical Discipline Is Slowly Declining as Some Studies Reveal Lasting Harms for Children” (p. 105)
· Cochran, J. L., Cochran, N. H., Nordling, W. J., McAdam, A., & Miller, D. T. (2010). Two case studies of child-centered play therapy for children referred with highly disruptive behavior.
International Journal of Play Therapy
,
19
(3), 130–143.
· Eyberg, S. M., Nelson, M. M., & Boggs, S. R. (2008). Evidence- based psychosocial treatments for children and adolescents with disruptive behavior.
Journal of Clinical Child and Adolescent Psychology
,
37
(1), 215–237.
· Pardini, D. A., Frick, P. J., & Moffitt, T. E. (2010). Building an evidence base for DSM-5 conceptualizations of oppositional defiant disorder and conduct disorder: Introduction to the special section.
Journal of Abnormal Psychology
,
119
(4), 683–688.
Media
· Laureate Education (Producer). (2014c).
Disruptive behaviors
[Video file]. Baltimore, MD: Author.
· Laureate Education (Producer). (2014d).
Disruptive behaviors: Part one
[Interactive media]. Baltimore, MD: Author.
· Laureate Education (Producer). (2014e).
Disruptive behaviors: Part two
[Interactive media]. Baltimore, MD: Author.
Disruptive Behaviors In the DSM-IV,
attention deficit and disruptive behaviors were grouped as a category within the classifications of disorders usually first diagnosed in infancy, childhood, and adolescence. Though it is true that these disorders are generally first diagnosed during these stages, the classifications of these disorders has been reconceptualized to reflect their similarities in manifestation, as well as considerations for the impact on social functioning. ADHD, for example, is grouped in the DSM-5 with neurodevelopmental disorders; research has supported a strong biol ...
Due Facilitating group to post by Day 1; all other students post AlyciaGold776
Due: Facilitating group to post by Day 1; all other students post to discussion prompt by Day 4 and one other peer initial discussion prompt post by Day 7
Initial Post: Created by Facilitating Group ( I am not in the facilitating group)
This is a student-led discussion.
· The facilitating group should choose one member from their group who will be responsible for the initial post.
· On Day 1 of this week, the chosen group member will create an initial post that is to include the group's discussion prompts, resources, and the instructions for what your classmates are to do with the resources.
· During this week, each member of your group is to participate in the facilitation of the discussion. This means making certain that everyone is engaged, questions from students are being answered, and the discussion is expanding.
· It is the expectation that the facilitating group will address all initial peer response posts by Day 7.
Reply Posts: Non-Facilitating Students
· If you are not a member of the facilitating group, you are to post a discussion prompt response according to the facilitating group's instructions by Day 4. Your reply posts should include substantive reflection directed to the presenters.
· You are also expected to respond to at least two other peer's initial discussion prompt posts.
Facilitating Group’s Post (to be replied)
Depression and Somatization Disorders
Barry Lynne, Brittany Stoken, and Jessica Murphy
NU664C: Psychiatric Mental Health Care of the Family I
November 1, 2021
Depression and Somatization Disorders
Hello Class,
Group 1 is assigned Depression and Somatization Disorders to further discuss. Failure to adjust and modify emotions cognitively while experiencing stress can ultimately present an outcome of exaggerated physiological and behavioral responses and amplify susceptibility to somatic disorders, such as somatization (Davoodi, et al., 2019). Somatization Disorder is the presentation of recurrent and multiple somatic complaints of several years duration for which medical attention has been sought but which do not derive from a specific physical disorder (Swartz, Blazer, & George, 2012).
Please respond to the following questions:
1. When caring for a patient with somatization disorder, what therapeutic interventions would you formulate (Allen, Woolfolk, Escobar, Gara, and Hamer, 2006)?
2. How would you evaluate the success of your interventions for a patient living with somatization?
Depression is an extremely serious mood disorder that effects how you think, feel, and act. Symptoms range from mild to severe including, feeling sad, loss of interest or pleasure, change in appetite, trouble sleeping or getting too much sleep, feeling worthless, difficulty concentrating, and thoughts of death or suicide (American Psychiatric Association, 2021). To be diagnosed with depression, symptoms must last at least two weeks and present a change in level of functioning (National Institute of Men ...
Reply to Comment· Collapse SubdiscussionEmilia EgwimEmil.docxlillie234567
Reply to Comment
·
Collapse SubdiscussionEmilia Egwim
Emilia Egwim
8:33amDec 21 at 8:33am
Manage Discussion Entry
Discussion for Comprehensive Focused Soap Psychiatric Evaluation
Hello Lovelyne
Great presentation; I really enjoy reading your presentation about your patient Joey which is very informative. Autism Spectrum disorder is a neurodevelopmental disorder that is associated with tenacious predicaments in social communication and interaction in addition with limited, continual model of behaviors. According to study by Fitzpatrick et al; indicated that aggression behavior are noted to be increased in individual with ASD than when compared with other neurodevelopmental impairments (2016). This aggressive behavioral issues has been indicated by studies to relate with obstructive consequences for children diagnosed with ASD and their care providers resulting in reduced quality of life, heightened stress levels and decreased accessibility of educational and social adaptation/acceptance. Studies indicated that establishing effective therapeutic and pharmacological intervention approach for treatment as well as preventing aggressive behavior is imperative for reaching to better outcomes for individual with ASD. The patient in this case presentation had history of ASD and endorses aggression and self-injuries behaviors which have been indicated by various studies to associated with ASD and other manifestation including hyperactive, impulsive, inattentive behavior, unusual mood or emotional reaction.
To answer your question “
Is Risperidone FDA approved for patients with Autism”
Based on various studies, Risperidone and aripiprazole are approved by FDA and recommended for treatment of schizophrenia and bipolar for adult and adolescent including children with Autism Spectrum disorder around age 5 to 16 years. The Risperidone an antipsychotic medication was recommended to treat the aggression, irritability and mood swings associated with ASD. According to study; Risperidone has been effecting in treating symptoms of aggression and irritability between the age of 5 and 6 years distinctly that is associated with ASD, however, there’s no FDA approved medication for treatment of core sign and symptoms of ASD (Alayouf et al, 2021). There have been several controversy surrounding the use of Risperidone in which several clinician trials conducted reported that the medication was effective for the agitation, aggression and irritability often observed in autism patient, but was less effective in treating the core symptoms of Autism and other argument including the undesirable side effects that are associated with the medication and most significant of which is weight gain from an increased appetite. Other several medication as well as off-label prescription has been indicated to be effective such as treatment with SSRIs, CNS stimulants, NMDA-receptor antagonists, and including other agents (LeClerc & Easley, 2015). I completely agree with th.
1
3
Test Development Proposal: Step One
Jane Doe
The University of Arizona Global Campus
RES7402: Advanced Tests & Measurements (QAH114DS)
Dr. John Doe
April 5, 2021
Test Development Proposal: Step One
Bushnell et al. 2019, describes depression disorder as disorder that affects an individual's mood, usually making them has an unrelenting feeling of sadness and interest loss (p.908). The condition leads to a variety of physical and emotional problems. The patients, therefore, experience trouble doing day-to-day activities. Older adults and women are at a high risk of this condition. Understanding the complexities 0f depression, diagnosis, and treatment has never been more critical, whether developing a better understanding of depression to an individual’s personal life, a team, and an organization that directly impacts communities. A better understanding of depression is also fundamental in offering innovative leadership ideas on handling this condition. This is especially very important because data illustrates that there are a lot of deaths that are attributed to depression.
In this construct, various characteristics can be assessed, but I will be assessing the symptoms of this condition in this case. Various characteristics are present to people suffering from this condition. Some of the characteristics include feelings of sadness and interest loss, suicidal tendencies, disturbed or lack of sleep, isolation, inactivity, low self-esteem, guilt, disturbed eating patterns, and overwhelming feelings. Most of the available instruments assess almost these entire characteristics, so it is essential to address them.
Tests and Instruments
Geriatric Depression Scale
The most widely used screening tools for depression among the elderly is the Geriatric Depression Scale (GDS). It is significant because of its validity and reliability (Guerin et al., 2018). GDS is a screening test that helps in the identification of depression symptoms in the aged group. Patients answer questions in a yes/no format. The questions asked how a high connection with depressive symptoms such as enjoyment level interest and social interaction, among others. The patient needs to be evaluated further if they get a score of 5 or above. This tool's significant advantage is it is easy and quick, taking less than 7 minutes to complete. However, its challenge is that it has been observed that some people may extend the time further as they may want to expound further regarding their issues. The assessor, therefore, has a duty of redirecting the patient back to the question time and again. Similarly, some people are too much into a depression that they find it difficult to answer the question, while others do not wish to answer some personal questions.
PHQ9
One of the most valuable tests is depression screening, also known as PHQ9. This is a criteria-based diagnosis of depressive disorder that is very reliable and valid in measuring the symptoms of depression. The is nin ...
1
3
Test Development Proposal: Step One
Jane Doe
The University of Arizona Global Campus
RES7402: Advanced Tests & Measurements (QAH114DS)
Dr. John Doe
April 5, 2021
Test Development Proposal: Step One
Bushnell et al. 2019, describes depression disorder as disorder that affects an individual's mood, usually making them has an unrelenting feeling of sadness and interest loss (p.908). The condition leads to a variety of physical and emotional problems. The patients, therefore, experience trouble doing day-to-day activities. Older adults and women are at a high risk of this condition. Understanding the complexities 0f depression, diagnosis, and treatment has never been more critical, whether developing a better understanding of depression to an individual’s personal life, a team, and an organization that directly impacts communities. A better understanding of depression is also fundamental in offering innovative leadership ideas on handling this condition. This is especially very important because data illustrates that there are a lot of deaths that are attributed to depression.
In this construct, various characteristics can be assessed, but I will be assessing the symptoms of this condition in this case. Various characteristics are present to people suffering from this condition. Some of the characteristics include feelings of sadness and interest loss, suicidal tendencies, disturbed or lack of sleep, isolation, inactivity, low self-esteem, guilt, disturbed eating patterns, and overwhelming feelings. Most of the available instruments assess almost these entire characteristics, so it is essential to address them.
Tests and Instruments
Geriatric Depression Scale
The most widely used screening tools for depression among the elderly is the Geriatric Depression Scale (GDS). It is significant because of its validity and reliability (Guerin et al., 2018). GDS is a screening test that helps in the identification of depression symptoms in the aged group. Patients answer questions in a yes/no format. The questions asked how a high connection with depressive symptoms such as enjoyment level interest and social interaction, among others. The patient needs to be evaluated further if they get a score of 5 or above. This tool's significant advantage is it is easy and quick, taking less than 7 minutes to complete. However, its challenge is that it has been observed that some people may extend the time further as they may want to expound further regarding their issues. The assessor, therefore, has a duty of redirecting the patient back to the question time and again. Similarly, some people are too much into a depression that they find it difficult to answer the question, while others do not wish to answer some personal questions.
PHQ9
One of the most valuable tests is depression screening, also known as PHQ9. This is a criteria-based diagnosis of depressive disorder that is very reliable and valid in measuring the symptoms of depression. The is nin ...
Respond by providing at least two contributions for improving .docxpeggyd2
Respond
by providing at least two contributions for improving or including in their Parent Guide and at least two things that you like about their guide.
NOTE: Positive comment
Main Discussion
ADHD Parent Guide
Attention-deficit/hyperactivity disorder (ADHD) is defined as a chronic neurological disorder characterized by a persistent pattern of inattention and/or hyperactivity/impulsivity. In 2016, it is estimated that 6.1 million or 9.4% of children had a diagnosis of ADHD (
Centers for Disease Control and Prevention
, n.d.). A diagnosis of ADHD can be both confusing and welcomed. Confusing because the details of the diagnosis are unknown but welcomed because the parents and child finally have a “why” for the child’s difficulties. This parent guide will discuss the pathophysiolology, diagnosing, signs/symptoms, treatment options, and other aspects involved in an ADHD diagnosis.
Pathophysiology
Many research studies suggest ADHD may be caused by interactions between genes and environmental or non-genetic factors. Many cases of ADHD have a genetic origin. A child is 50% more likely to have ADHD if their parent was diagnosed with the condition and 25% of the children with ADHD have parents who have met the criteria for a diagnosis of ADHD. Other factors that can contribute to ADHD is substance use, low birth weight, brain injuries and exposure to some environmental toxins.
ADHD is a result of neurotransmitter disease dysfunction, that effect dopamine and norepinephrine. Dopamine has a role in a person's ability to learn and reinforcing trained response to various situations. Dopamine also plays and important role in "working memory"(
Attention-deficit Hyperactivity Disorder
, 2004). Norepinephrine effects a person's alertness and attention. Norepinephrine is activated by novel and important stimuli and are quiescent during sleep.
Environmental factors of ADHD is a result of a toxin such as lead or other nuero-toxic substances that may result in delayed development of the child's brain before, during or birth. Substance abuse is a very common cause of pre- and perinatal factors that may result in ADHD. Exposure of the fetus to alcohol is associated with a reduction in the volume of the prefrontal and temporal cortices, the brain areas involved in regulation of attention and control of impulsivity. (
Attention-deficit Hyperactivity Disorder
, 2004)
Diagnosing ADHD
While there is no single test to diagnosis ADHD, there are ways to obtain an accurate diagnosis.
Who diagnosis ADHD?
There are many health care professionals who are qualified to diagnose ADHD. These professionals include but are not limited to psychiatrist, psychiatric mental health nurse practitioner (PMHNP), licensed master social worker (LMSW), licensed professional counselor (LPC), neurologist, pediatricians, and primary care physicians. If there is a concern that a ch.
15 Disruptive, Impulse-Control, and Conduct DisordersThis chapte.docxherminaprocter
15 Disruptive, Impulse-Control, and Conduct Disorders
This chapter contains an amalgam of disruptive, impulse-control and conduct disorders (CDs) characterized by externalizing behaviors previously spread throughout many chapters of earlier DSM editions. However, these disorders are no longer categorized by age (e.g., disorders of infancy, childhood, and adolescence), and all share the loss of restraint (i.e., poor control) in terms of an individual's emotional or behavioral responses that are demarcated by an infringement on the rights of others or breach of social norms. Attention should be paid to the symptom overlap that these diverse disorders share with Attention Deficit/Hyperactivity Disorder (ADHD) (which can be found in on Neurodevelopmental Disorders); Disruptive Mood Dysregulation Disorder (DMDD) (which can be found in on Depressive Disorders); Substance Use Disorders (SUDs) (the adjoining ), as well as Antisocial Personality Disorder (which has a dual recording in both this chapter and in on Personality Disorders) ().
First on the hierarchical spectrum of externalizing disorders in this chapter is Oppositional Defiant Disorder (ODD). An individual with must display at least four out of eight symptoms/behaviors with an individual who is not a sibling for at least 6 months from the following three categories: (1) angry/irritable mood; (2) argumentative/defiant behavior; and (3) vindictiveness. For example, argumentative/defiant behavior symptoms include: being argumentative; demonstrating a lack of compliance with authority figures' requests; annoying others deliberately; and blaming others for his or her mistakes. The anger/irritability category symptoms include loss of temper; getting easily upset and/or annoyed, and anger/resentment. The final category has only one symptom vindictiveness or spitefulness demonstrated at least two times within the previous 6 months ().
Many symptoms of this diagnosis are commonly displayed during normal childhood/adolescent developmental stages. Therefore, in an effort to help differentiate the symptoms that are characteristic of this diagnosis, practitioners are cautioned to consider the persistence and frequency of behaviors. For example, in young children under the age of 5, the symptoms must occur for the majority of days for at least 6 months. For older individuals, the symptoms must occur at least once weekly within a 6-month period. However, for vindictiveness regardless of age, the criterion is the same, twice within the previous 6-month period. Along with frequency, other factors must be taken into consideration, such as symptom intensity, and whether symptoms are normal given the individual's age, developmental stage, gender, and culture. In addition, the symptoms must cause significant suffering in the individual or in his/her immediate relationships (e.g., family, friends, peers) as well as impairment in psychosocial functioning. Further, the symptoms cannot manifest only durin.
AssignmentWrite a Respond to two of these #1&2 case studies.docxnormanibarber20063
Assignment:
Write a Respond to two of these #1&2 case studies using one or more of the following approaches:
Share additional interview and communication techniques that could be effective with your colleague’s selected patient.
Suggest additional health-related risks that might be considered.
Validate an idea with your own experience and additional research.
Each must have at least 2 references no more than 5 years old using APA Format
Response # 1
“The case of physician do not heal thyself”
Three questions I will ask the patient on a visit to my office and rationale thereof.
Major depressive disorder (MDD) is defined as “feelings of sadness and/or a loss of interest in activities once enjoyed. It can lead to a variety of emotional and physical problems and can decrease a person’s ability to function at work and at home” and it is one of the most common reasons patients present for medical care worldwide (McConnell, Carter & Patterson, 2019). Childhood traumatic experiences, including physical, sexual, and emotional abuse, neglect, and separation from caregivers, they posit significantly increase the risk of developing mental and physical illnesses later in life.
NO .1
Have you had any thoughts of death or suicide before? Are you having them now? And do you have a current plan to harm or kill yourself? What are the details of that plan?
McConnell,et .al, (2019) posit that clients with MDD often presents with feeling sad or depressed; lack of interest or pleasure in previously enjoyed activities; appetite changes (unintentional weight loss or gain); sleep difficulty (too much or little); lack of energy (fatigue); feeling of guiltiness or worthlessness; moving more slowly or pacing (others observe); difficulty with decision-making, concentration, and thinking; and/or suicidal thoughts.
Patient safety remains a central concern in every healthcare setting (Smith,2018). This patient did report several feelings of Suicide Ideation and Homicidal ideation so patients’ safety should be priority. Although the welfare of patients encompasses a broad range of concerns, the increasing prevalence of suicide in our society compels health care workers to ensure a safe healthcare environment for patients with suicidal ideation. These efforts include the elimination or, at least, the mitigation of physical setting characteristics that enable suicide attempts.
No 2.
Are you depressed? How does this problem make you feel? What makes the problem better?
According to DSM-5 (2013) diagnostic criteria, MDD requires five or more of the following symptoms during the same two-week period and represent a change from previous functioning; at least one symptom is either 1) depressed mood or 2) loss of interest or pleasure (American Psychiatric Association [APA], 2013).
According to the patient’s file, he has experienced five or more of the symptoms of MDD during the same two-week period, on more than one occasion, incl.
Learning Resources to be used as references to support your answer.docxsmile790243
Learning Resources to be used as references to support your answer.
USW1_SOCW_6090_howToWriteADiagnosisInDSM5.pdfUSW1_SOCW_6090_WK03_Chase.pdf
Note: To access this week’s required library resources, please click on the link to the Course Readings List, found in the Course Materials section of your Syllabus.
Required Readings
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
· “Neurodevelopmental Disorders” (pp. 31–86)
· “Other Conditions That May Be a Focus of Clinical Attention” (pp. 715–727)
Bell, A. S. (2011). A critical review of ADHD diagnostic criteria: What to address in the DSM-V. Journal of Attention Disorders, 15(1), 3–10.
Note: You will access this article from the Walden Library databases.
How to Write a Diagnosis According to DSM-5 and ICD-10-CM (PDF)
Teicher, M. H., Samson, J. A., Polcari, A., & McGreenery, C. E. (2006). Sticks, stones, and hurtful words: Relative effects of various forms of childhood maltreatment. American Journal of Psychiatry, 163(6), 993–1000.
Note: You will access this article from the Walden Library databases.
Working With Children and Adolescents: The Case of Chase (PDF)
Wing, L., Gould, J., & Gillberg, C. (2011). Autism spectrum disorders in the DSM-V: Better or worse than the DSM-IV? Research in Developmental Disabilities, 32, 768–773.
Note: You will access this article from the Walden Library databases.
Wiki Assignment Instructions (PDF)
Kieling, C., Kieling, R. R., Frick, P. J., Rohde, L. A., Moffitt, T., Nigg, J. T., Tannock, R., & Castellanos, F. X. (2010) The age at onset of attention deficit hyperactivity disorder. American Journal of Psychiatry, 167, 14–15.
Note: You will access this article from the Walden Library databases.
Murphy, C., & Taylor, E. (2006). Need to know ADHD. Pulse, 66(34), 38–42.
Note: You will access this article from the Walden Library databases.
Discussion - Week 3
Collapse
Top of Form
Total views: 35 (Your views: 4)
Discussion: Influences on Diagnosis and Outcome
The addition of more Z Codes to the DSM-5 is congruent to how a social worker as a clinician should conduct an assessment and determine the appropriate treatment.
For this Discussion, review The Case of Chase, analyze Chase’s story, and note his original DSM-IV diagnosis. Using the DSM-5 diagnostic criteria, determine Chase’s primary clinical diagnosis. Next, note the changes in the Autism Spectrum disorders, and include the Other Conditions That May Be a Focus of Clinical Attention (ICD-10-CM, Z codes) in your diagnosis. Then identify the potential risk and prognostic factors from both the biological and environmental perspective.
By Day 3
Post your response to the following:
· What should Chase’s diagnosis be according to the DSM-5 criteria?
· What predisposing and risk factors led to the outcome of this case?
· What potential protective factors could have been introduced to address this situation?
· ...
R E V I E WAnxiety disordersCornelia Mohr • Silvia Sch.docxcatheryncouper
R E V I E W
Anxiety disorders
Cornelia Mohr • Silvia Schneider
Published online: 12 December 2012
� Springer-Verlag Berlin Heidelberg 2012
Abstract With the adoption of a developmental psycho-
pathology perspective, the DSM-5 translates empirical
evidence on the continuity of childhood anxiety disorders
into diagnostic practice, thereby completing a process that
started with the exclusion of the former childhood anxiety
disorders overanxious disorder and avoidant disorder from
DSM-III to DSM-IV. This change in perspective, however,
leads to a low level of concordance between the DSM-5
and ICD-10. To reliably identify anxiety disorders at dif-
ferent points in development, and to take into account their
developmental pathways, assessment instruments need to
be sensitive to age-related manifestations and age-related
subtypes of a disorder. This may best be achieved by a
multi-informant, multi-method assessment approach. With
regard to treatment, only cognitive-behavioral therapy
(CBT) fulfills the criteria of an evidence-based treatment
approach in youth. Disorder-specific treatments can lead to
larger treatment effects and slightly higher remission rates
as compared to more general treatment programs for
childhood anxiety disorders (e.g., Coping Cat). Parental
involvement seems not to add to treatment success. In
conclusion, the evidence-based diagnostic approach of the
DSM-5 needs to be complemented by the development and
evaluation of child-friendly, developmentally sensitive
assessment tools and evidence-based treatments for anxiety
disorders in children. With regard to diagnostic concor-
dance, the gap between the DSM-5 and ICD-10 needs to be
bridged by more closely aligning the two nosological
systems.
Keywords DSM-IV � DSM-5 � ICD-10 � Separation
anxiety disorder � Specific phobia � Social anxiety disorder �
Generalized anxiety disorder � CBT � Childhood �
Adolescence
A developmental lifespan perspective on anxiety
disorders
With lifetime prevalence estimates ranging from 15 % to
20 % and a median age of onset of 11 years [1], anxiety
disorders are among the most prevalent and earliest
forms of psychopathology [2] and are known to function
as a pacemaker for mental disorders later in life [3–5].
Yet, research on anxiety disorders in younger populations
lags behind studies on anxiety disorders in adults. The
adoption of a developmental psychopathology perspective
is one of the major changes from DSM-IV to DSM-5.
This change might gradually shift the focus of researchers
and clinicians toward a clinical psychology of the
lifespan.
Continuity in diagnostic criteria across age groups
With regard to defining the criteria for diagnosing anxiety
disorders in different age groups, empirical evidence sup-
ports continuity in criteria (as in DSM-IV-TR and DSM-5)
instead of applying different criteria to children/adoles-
cents and adults (as in ICD-10). Contracting an anxiety
disorder at any ti ...
Due Facilitating group to post by Day 1; all other AlyciaGold776
Due: Facilitating group to post by
Day 1; all other students post to discussion prompt by
Day 3 and one other peer initial discussion prompt post by
Day 6
Initial Post: Created by Facilitating Group ( I am not in the facilitating group)
This is a student-led discussion.
· The facilitating group should choose one member from their group who will be responsible for the initial post.
· On
Day 1 of this week, the chosen group member will create an initial post that is to include the group's discussion prompts, resources, and the instructions for what your classmates are to do with the resources.
· During this week, each member of your group is to participate in the facilitation of the discussion. This means making certain that everyone is engaged, questions from students are being answered, and the discussion is expanding.
· It is the expectation that the facilitating group will address all initial peer response posts by Day 7.
Reply Posts: Non-Facilitating Students
· If you are not a member of the facilitating group, you are to post a discussion prompt response according to the facilitating group's instructions by
Day 3. Your reply posts should include substantive reflection directed to the presenters.
· You are also expected to respond to at least two other peer's initial discussion prompt posts.
Group Facilitated Discussion Plan: Attention Deficit Hyperactivity Disorder
Yanisleidy Mondeja and Laura Richard
NU664C Family Mental Health I
Attention Deficit Hyperactivity Disorder
This post entails an alliance of ideas and research blended to inspire a lively discussion entailing Attention Deficit Hyperactivity Disorder (ADHD) among children and adolescents. ADHD is one of the most common mental disorders affecting children and adolescents. Thomas et al. (2015) affirm that it is a common neurobehavioral disorder, with approximately 11% of children aged 4 to 17years being diagnosed in the United States alone. The presence of geographical differences affects the rate of diagnosis and treatment in which prevalence has increased over time. Considering the fifth edition of DSM-V, for an individual to be diagnosed with ADHD, one must meet six out of nine possible inattentive symptoms such as failing to give close attention to details or being easily distracted. This is alongside the six out of nine possible hyperactivity or impulsivity symptoms such as being on the ego or difficulty for an individual to wait for his turn. Moreover, symptoms need to be present for at least six months, occur in two different settings, be present before 12 years of age, and not be better explained by another disorder (Painter & Scannapieco, 2021).
Attention Deficit-Hyperactivity Disorder has three presentations: predominantly hyperactive/impulsive, predominantly inattentive, and a combination of the two based on how many symptoms in each diagnostic category a person meets. ...
Similar to Evidence-based counseling therapies for attention-deficit/hyperactivity disorder in adults (20)
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
2. Attention Deficit/Hyperactivity Disorder (ADHD) in Adults
• ADHD originally was considered to be a childhood disorder that
disappeared with age (Lange, Reichl, Lange,Tucha, &Tucha, 2010).
• Recognition arose during the 1990s that it is a chronic, persistent disorder
that remains in adulthood in many cases (Lange, Reichl, Lange,Tucha, &
Tucha, 2010).
• The estimated prevalence rate for adult ADHD ranges between 1% and 6%
of the adult population in the United States (Kolar et al., 2008).
• In adult ADHD patients, inattention, disorganization, and impulsivity can
bring about functional difficulties at home, at college, and at the workplace
(Kolar et al., 2008).
• Adults with ADHD also exhibit a higher prevalence of anxiety, depression,
and antisocial behaviors than the general population (Kolar et al., 2008).
3. The Changing Conceptualization of Adult ADHD
• The conceptualization of a disorder has important implications for the way
we diagnose and treat that disorder (Maddux & Winstead, 2012, p. 3).
• DSM–IV (APA, 1993) is the first diagnostic manual to consider a diagnosis of
ADHD in an adult patient (Lange, Reichl, Lange,Tucha, &Tucha, 2010).
• Under DSM-IV, ADHD was grouped with the disruptive behavior disorders
(APA, 1993). This conceptualizes ADHD as primarily a behavioral issue.
• Under DSM-5, ADHD is considered to be one of the neurodevelopmental
disorders (APA, 2013). This conceptualization views ADHD as an issue
having neurodevelopmental roots and perhaps requiring a multifaceted
approach to treatment.
• This is particularly important in treating adults diagnosed with ADHD, as
these issues may be all the more deeply rooted and consequently more
complex to treat (Kolar et al., 2008).
4. Diagnostic Criteria of Adult ADHD under DSM-IV
In order to establish a diagnosis of ADHD, whether for child or adult, under
DSM-IV, the patient’s clinical presentation must satisfy five criteria:
A. At least six symptoms of inattention or hyperactivity-impulsivity have
persisted for at least six months, to a degree that is maladaptive and
inconsistent with developmental level.
B. These symptoms were present prior to the age of seven.
C. Impairment is manifested in at least two different settings.
D. Clear evidence is presented of clinically significant impairment in social,
academic, or occupational functioning.
E. The symptoms do not occur during the course of certain other disorders
and are not better accounted for by another mental disorder (APA, 2000,
pp. 92-93).
5. Diagnostic Criteria of Adult ADHD under DSM-IV
It is in the discussion of the typical course of the disorder that DSM-IV
highlights, albeit briefly, the diagnosis of ADHD in adults:
In most individuals, symptoms (particularly motor hyperactivity) attenuate
during late adolescence and adulthood, although a minority experience the
full complement of symptoms of Attention-Deficit/Hyperactivity Disorder
into mid-adulthood. Other adults may retain only some of the symptoms,
in which the diagnosis of Attention-Deficit/Hyperactivity Disorder, In Partial
Remission, should be used. The latter diagnosis applies to individuals who
no longer have the full disorder but still retain some symptoms that cause
functional impairment. (APA, 2000, p. 90)
6. Diagnostic Criteria of Adult ADHD under DSM-5
In order to establish a diagnosis of ADHD, whether for child or adult, under
DSM-5, the patient’s clinical presentation must satisfy five criteria:
A. At least five symptoms of inattention or hyperactivity-impulsivity have
persisted for at least six months, to a degree that is inconsistent with
developmental level and that negatively impact directly on social and
academic/occupational activities.
B. These symptoms were present prior to the age of twelve.
C. Impairment is manifested in at least two different settings.
D. Clear evidence is presented of clinically significant impairment in social,
academic, or occupational functioning.
E. The symptoms do not occur during the course of certain other disorders
and are not better accounted for by another mental disorder (APA, 2013,
pp. 59-60).
7. Diagnostic Criteria of Adult ADHD under DSM-5
Although the broad view of the disorder may have shifted with the
implementation of DSM-5, the specific diagnostic criteria for adult ADHD
remain basically the same as that in DSM-IV, with two notable exceptions:
1. The age of onset of symptoms is raised from seven years old under DSM-
IV (APA, 1993) to twelve years old under DSM-5 (APA, 2013). This shift
“conveys the importance of a substantial clinical presentation during
childhood” while also acknowledging the “difficulties in establishing
precise childhood onset retrospectively” (APA, 2013, p. 61).
2. The threshold number of symptoms necessary to establish a diagnosis of
ADHD in an adult (age 17 or older) is lowered from six in DSM-IV (APA,
1993) to five in DSM-5 (APA, 2013). This acknowledges both the fact that
the behaviors attendant with ADHD tend to diminish as development
proceeds from adolescence into adulthood (Kolar et al., 2008), yet can still
pose clinically significant impairment in the adult due to the complex and
different demands imposed by these symptoms upon the adult (Kolar et
al., 2008).
8. Coding Specifiers of Adult ADHD under DSM-5
Under DSM-5, ADHD is coded under one of three subtypes:
• 314.00 (F90.0) Attention-Deficit/Hyperactivity Disorder, Predominantly
inattentive presentation.
• 314.01 (F90.1) Attention-Deficit/Hyperactivity Disorder, Predominantly
Hyperactive/impulsive presentation.
• 314.01 (F90.2) Attention-Deficit/Hyperactivity Disorder, Combined
presentation. (APA, 2013, p. 60).
DSM-5 also codes severity according to three categories:
1. Mild – few symptoms and minor impairment in functioning;
2. Moderate - symptoms and impairments fall between “mild” and “severe;”
3. Severe – many or particularly severe symptoms, or marked impairments
in functioning (APA, 2013, pp. 60-61).
9. Additional Categories of Adult ADHD under DSM-5
The DSM-5 includes two additional categories of ADHD. Both of these
categories share a clinical presentation of symptoms characteristic of ADHD
and clinically significant distress or impairment in functioning within social,
occupational, or other important areas, yet the diagnostic criteria for ADHD
or another neurodevelopmental disorder are not fully satisfied (APA, 2013, pp.
65-66) .
• “Other Specified Attention-Deficit/Hyperactivity Disorder (314.01; F90.8) is
used when the clinician “chooses to communicate the specific reason that
the presentation does not meet the criteria (APA, 2013, pp. 65-66).
• “Unspecified Attention-Deficit/Hyperactivity Disorder” (314.01; F90.9) is
used when the clinician chooses not to communicate that reason, and may
include the case in which there is insufficient information to make a more
specific diagnosis (APA, 2013, p. 66).
10. Evidence-Based Counseling Therapies for Adult ADHD
• “Although there is no cure for ADHD, there are well-established and
evidence-based options for the treatment of adults with the disorder” (Daly,
Nicholls, & Brown, 2016, p. 45).
• Many experts consider pharmacotherapy, particularly with stimulants, to be
the primary treatment option for adults (Daly, Nicholls, & Brown, 2016, p.
45).
• However, nearly half of all adult patients with ADHD are not able to tolerate
these medications, do not respond to them, or fail to reach optimal
outcomes on medication alone (Dittner, Rimes, Russell, & Chalder, 2014).
11. Evidence-Based Counseling Therapies for Adult ADHD
• As applied in the treatment of ADHD, cognitive behavioral therapy provides
structure as well as coping and problem-solving skills (Daly, Nicholls, &
Brown, 2016, p. 52).
• The specific strategies associated with cognitive behavioral therapy include
assisting the client to identify and modify negative cognitions associated
with the task avoidance, lack of motivation, and negative affect. The
therapist then assists the client in challenging these negative cognitions,
with the goal of diminishing hopelessness and increasing motivation (Daly,
Nicholls, & Brown, 2016, p. 52).
• In a review study of psychotherapeutic treatments for adult ADHD byVidal-
Estrada and colleagues (2012), cognitive behavioral therapy was “the most
effective treatment modality for reducing symptoms of ADHD as well as
comorbid symptoms of anxiety and depression” (Daly, Nicholls, & Brown,
2016, p. 52).
Cognitive
Behavioral
Therapy
12. Evidence-Based Counseling Therapies for Adult ADHD
• Meta-cognitive therapy, which uses cognitive behavior principles, can
provide a framework for organizational interventions in adult ADHD cases
(Daly, Nicholls, & Brown, 2016, p. 53).
• In this therapeutic system, counselors help clients to challenge and
subsequently eliminate maladaptive cognitions, replacing them with
adaptive cognitions that lead to better organization and on-time task
completion. The therapist and client collaborate on establishing a system of
rewards for timely completion of tasks, which reinforces the desired
behavior and shapes a positive the cognitive-behavioral pathway (Daly,
Nicholls, & Brown, 2016, p. 53).
• Studies of the effectiveness of meta-cognitive therapy with adult ADHD clients
have demonstrated significant improvement in attention and organizational skills
(Wiggins et al., 1999) as well as decreases in severity ofADHD symptoms (Solanto
et al., 2010), suggesting that this a promising avenue of treatment for adult ADHD
patients (Daly, Nicholls, & Brown, 2016, p. 53).
Meta-
Cognitive
Therapy
13. Evidence-Based Counseling Therapies for Adult ADHD
• Support therapy and family therapy are treatment modalities for adult
sufferers of ADHD that are effective not only in treating low-esteem, poor
anger control, and the like, but in redeveloping relationships within peer
networks and family members (Daly, Nicholls, & Brown, 2016, p. 53).
• These system-oriented approaches aim to resolve the client’s inaccurate
judgments about himself as well as the inaccurate judgments of others
about the client’s symptoms and underlying disorder (Daly, Nicholls, &
Brown, 2016, p. 52).
• These therapies consequently present a hopeful, multifaceted approach to
the complex of personal and interpersonal problems encountered by the
adult ADHD patient and his social network. (Daly, Nicholls, & Brown, 2016,
p. 54).
Supportive
Therapy
and
Family
Therapy
14. Conclusions
• The problems presented by an adult sufferer of attention-
deficit/hyperactivity disorder are complex and challenging.
• The conceptualizations of adult ADHD in DSM-IV-TR and DSM-5 provide
research-based guidance in approaching the diagnosis and treatment of this
disorder.
• While it is a complex neurodevelopmental disorder that is all the more
challenging to treat in the adult, several evidence-based treatment
modalities provide hope for the client and encouragement for the therapist
in overcoming the symptoms of this chronic and pervasive disorder, so that
the adult having ADHD can cope and thrive.
15. References
American Psychiatric Association. (2000). Diagnostic and statistical manual of
mental disorders (4th ed., text revision). Washington, DC: American
Psychiatric Association.
American Psychiatric Association. (2013). Diagnostic and statistical manual of
mental disorders (5th ed.).Washington, DC: American Psychiatric Association.
Daly, B. P., Nicholls, E., & Brown, R.T. (2016). Attention-deficit/hyperactivity
disorder in adults. Boston, MA: Hogrefe Publishing.
Dittner, A. J., Rimes, K.A., Russell, A. J., & Chalder,T. (2014). Protocol for a
proof of concept randomized controlled trial of cognitive-behavioural therapy
for adult ADHD as a supplement to treatment as usual, compared with
treatment as usual alone. BMC Psychiatry, 14:248. doi:10.1186/s12888-014-
0248-1.
16. References
Kolar, D., Keller, A., Golfinopoulos, M., Cumyn, L., Syer, C., & Hechtman, L.
(2008).Treatment of adults with attention-deficit/hyperactivity disorder.
Neuropsychiatric Disease andTreatment, 4(2), 389–403.
Lange, K.W., Reichl, S., Lange, K. M.,Tucha, L., &Tucha, O. (2010).The
history of attention deficit hyperactivity disorder. Attention Deficit
Hyperactivity Disorder, 2, 241–255. doi:10.1007/s12402-010-0045-8
Maddux, J. E., &Winstead, B. A. (2012). Psychopathology: Foundations for a
contemporary understanding (3rd ed.). NewYork, NY: Routledge.
Paris, J., Bhat,V., &Thombs, B. (2015). Is adult attention-deficit hyperactivity
disorder being overdiagnosed? CanadianJournal of Psychiatry, 60(7), 324–
328.